Investment
Features
FeesSafety
Academy
More
Pluang+

Theralase announces up to C$5M private placement to fund cancer and virus treatment studies

Company Fundamentals
10 Aug 2026
Newsfile Corp
View Source
Bullish
pluang ai news

Theralase Technologies Inc. has launched a private placement to raise between C$3 million and C$5 million by issuing units at C$0.24 each, including shares and warrants exercisable until 2031. The funds will support toxicology studies for their cancer treatment Rutherrin® and a topical treatment for herpes simplex virus cold sores, as well as general corporate purposes. The offering is expected to close by August 24, 2026, subject to regulatory approvals. This financing aims to advance Theralase's clinical development and commercialization efforts for its energy-activated small molecule therapies targeting cancer and viral infections.

More News (TLT)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App